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Carnitine palmitoyltransferase (CPT) 1C, a brain-specific protein localized in the endoplasmic re-
ticulum of neurons, is expressed in almost all brain regions. Based on global knockout (KO) models,
CPT1C has demonstrated relevance in hippocampus-dependent spatial learning and in hypotha-
lamic regulation of energy balance. Specifically, it has been shown that CPT1C is protective against
high-fat diet–induced obesity (DIO), and that CPT1C KO mice show reduced peripheral fatty acid
oxidation (FAO) during both fasting and DIO. However, the mechanisms mediating CPT1C-dependent
regulation of energy homeostasis remain unclear. Here, we focus on themechanistic understanding of
hypothalamic CPT1C on the regulation of fuel selection in liver andmuscle of malemice during energy
deprivation situations, such as fasting. In CPT1C-deficient mice, modulation of the main hypothalamic
energy sensors (50 adenosine monophosphate-activated protein kinase, Sirtuin 1, and mammalian
target of rapamycin) was impaired and plasma catecholamine levels were decreased. Consequently,
CPT1C-deficientmice presented defective fasting-induced FAO in liver, leading to higher triacylglycerol
accumulation and lower glycogen levels. Moreover, muscle pyruvate dehydrogenase activity was in-
creased, which was indicative of glycolysis enhancement. The respiratory quotient did not decrease in
CPT1CKOmice after 48hours of fasting, confirmingadefective switchon fuel substrate selectionunder
hypoglycemia. Phenotype reversion studies identified themediobasal hypothalamus (MBH) as themain
areamediating CPT1C effects on fuel selection. Overall, our data demonstrate that CPT1C in theMBH is
necessary for proper hypothalamic sensing of a negative energy balance and fuel partitioning in liver
and muscle. (Endocrinology 158: 2226–2238, 2017)
The hypothalamus plays a central role in energy bal-ance regulation in mammals because it integrates the
metabolic status of the organism through metabolite,
hormone, and nutrient sensing. Several studies have
clearly shown the involvement of hypothalamic lipid
metabolism in regulation of food intake and energy
homeostasis (1). Among the different lipid players, it is
important to mention carnitine palmitoyltransferase
ISSN Print 0013-7227 ISSN Online 1945-7170
Printed in USA
Copyright © 2017 Endocrine Society
Received 10 February 2017. Accepted 28 April 2017.
First Published Online 3 May 2017
Abbreviations: AMPK, adenosine monophosphate–activated protein kinase; CPT, car-
nitine palmitoyltransferase; DIO, high-fat diet–induced obesity; eWAT, epidydimal white
adipose tissue; FAO, fatty acid oxidation; GFP, green fluorescence protein; HRP, horse-
radish peroxidase; KO, knockout; LCFA, long-chain fatty acid; MBH, mediobasal hypo-
thalamus; mTOR, mammalian target of rapamycin; NEFA, nonesterified fatty acid; PCR,
polymerase chain reaction; PDH, pyruvate dehydrogenase; PDK4, pyruvate de-
hydrogenase 4; PEPCK, phosphoenolpyruvate carboxykinase; RQ, respiratory quotient;
RRID, Research Resource Identifier; SEM, standard error of the mean; Sirt1, Sirtuin 1; TAG,
tissue triacylglycerol; UCP2, uncoupling protein 2; WT, wild-type; w/v, weight-to-
volume ratio.
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(CPT) 1 enzymes, malonyl-CoA, long-chain fatty acids
(LCFAs), ceramides, uncoupling protein 2 (UCP2), or
lipoprotein lipase (2–11). Most of these molecules are
downstream factors of 50 adenosine monophosphate–
activated protein kinase (AMPK), a hypothalamic key
energy sensor that responds to peripheral hormones and
to food scarcity to preserve appetite and regulate pe-
ripheral metabolism (12–14).
In this study, we focused on the role of hypothalamic
CPT1C in the regulation of fuel selection by peripheral
tissues during fasting. CPT1C is a downstream factor of
AMPK, whose expression levels increase in response to
AMPK activation (15). Contrary to the other CPT1
isoforms (i.e., CPT1A and CPT1B), CPT1C is located in
the endoplasmic reticulum of neurons instead of the outer
membrane of mitochondria, and has negligible CPT1
activity (16, 17). However, it is able to bindmalonyl-CoA
and LCFA-CoAs with similar affinities than CPT1A (16,
18, 19), suggesting that it might act as a sensor of these
lipid intermediaries in hypothalamus (8). In fact, it has
been involved in hypothalamic leptin and ghrelin sig-
naling pathways in the control food intake (20, 21).
Moreover, its deletion reduces peripheral fatty acid ox-
idation (FAO) induction in response to high-fat diet or
fasting, leading to an obesogenic phenotype (19, 22, 23).
However, the molecular and physiological mechanisms
leading to those effects are completely unknown.
Here, we describe the metabolic inflexibility shown by
CPT1C knockout (KO) mice in response to changes in
nutrient availability. Specifically, we focus on the met-
abolic parameters and signaling pathways in the hypo-
thalamus, plasma, liver, and muscle of CPT1C KO mice
during fasting. Our results show that CPT1C-deficient
mice exhibit a continuous fed-like hypothalamic energy
sensor status during food deprivation, resulting in de-
creased plasma catecholamine levels and impaired he-
patic and muscular fuel partitioning. Moreover, we
identify the mediobasal hypothalamus (MBH) as the area
of CPT1C function responsible for these effects.
Materials and Methods
Animals
We used 8- to 10-week-old male CPT1C KO mice (24) in a
C57BL/6J background. They were housed in a controlled en-
vironment (i.e., 12 hours of light and 12 hours of dark) with free
access to food and water. For fasting experiments, animals were
either food-deprived 1 hour after beginning the light cycle
(09:00) for a total of 24 hours (fasted) or fed ad libitum (fed).
After this period, they were euthanized by cervical dislocation.
MBH, liver, muscle (gastrocnemius), and epidydimal white
adipose tissue (eWAT) were dissected and stored at280°C. To
dissect the MBH, brains were placed in a coronal brain matrix
(Roboz Surgical Instrument, Gaithersburg, MD) and sectioned
from bregma (21 mm to 22.5 mm). Then the MBH was
obtained from each section, using a tissue collector measuring
1 mm in diameter. Six- and 48-hour fasting experiments were
performed to analyze liver and muscle glycogen stores as well as
body weight and glycemia. Animal procedures were carried out
in accordance with Spanish legislation (BOE 32/2007), EU
Directive 2010/63/EU for animal experiments, and were ap-
proved by the local ethics committee.
Indirect calorimetry, locomotor activity, and body
composition analysis
Mice were analyzed for energy expenditure, respiratory
quotient (RQ), and locomotor activity using a calorimetric
system (LabMaster; TSE Systems, Bad Homburg, Germany), as
previously shown (25–27). Mice were placed for adaptation for
1 week before starting the measurements. For the measurement
of body composition, we used nuclear magnetic resonance
imaging (Whole Body Composition Analyzer; EchoMRI,
Houston, TX), as previously shown (28, 29). We used six
animals per experimental group.
Lentivirus production and hypothalamic delivery
Two lentiviral vectors, pWPI-IRES-GFP and pWPI-CPT1C-
IRES-GFP, were constructed to drive the expression of green
fluorescence protein (GFP) and CPT1C plus GFP, respectively.
The map and sequences of these plasmids are available at
Addgene (Cambridge, MA). Lentiviruses were propagated and
titrated as previously described (30). Stereotaxic surgery to
target the MBH was performed under ketamine/xylazine an-
esthesia. Mice were injected with lentivirus particles (1 3 109
pfu/mL; 500 nL/side over 10 minutes; injection rate, 50 nL/min)
using a Hamilton syringe (catalog no. 65460-02; Hamilton
Robotics, Bonaduz, Switzerland). The coordinates used from
bregma were as follows: anterior/posterior,21.5; lateral,60.4;
dorsal/ventral,25.8.Mice underwent 1week of recovery before
other experiments were performed. Correct bilateral MBH
infection was confirmed histologically by GFP fluorescence in
brain sections.
Pyruvate tolerance test
Pyruvate (2 g/kg; Sigma-Aldrich, Madrid, Spain) was ad-
ministered intraperitoneally after 15 hours of fasting. Blood
samples were collected from the tail vein and glucose concen-
trations were measured using a Glucometer Elite (Bayer, Bar-
celona, Spain) at baseline and at the indicated times after
intraperitoneal administration.
Tissue triacylglycerol and glycogen quantification
For tissue triacylglycerol (TAG) and glycogen quantification,
pulverized frozen tissue (100mg) was homogenized in 500mL
of phosphate-buffered saline. Lipids were extracted using
chloroform, dried under a N2 stream, and redissolved in
n-propanol. TAGs were quantified using the Triglycerides De-
termination Kit (Linear Chemicals, Barcelona, Spain). Glycogen
extraction and quantification were performed as previously
described (31) after 6 hours of fasting, with minor modifica-
tions. Briefly,muscle or liver tissue (100mg)was homogenized
with 250 mL of potassium hydroxide 30% [weight-to-volume
ratio (w/v)] and digested at 95°C for 15minutes. Then 120mL of
homogenate was placed on 23 2 cmWhatman filter paper and
dried before adding 66% cold ethanol (volume-to-volume ratio)
for glycogen precipitation. After three washes with ethanol,
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filters were dried again and incubated with 1 mL of glycogen
digestion solution (0.5 mg/mL of amyloglucosidase in 400 mM
sodium acetate at pH 4.8) at 37°C for 90 minutes to hydrolyze
glycogen into glucose monomers. Glucose samples were quan-
tified using the Glucose Determination Kit (Linear Chemicals,
Barcelona, Spain).
Plasma metabolite analysis
Catecholamine levels in plasma were measured in fed and
fasting conditions using a 2-CAT Research enzyme-linked
immunosorbent assay kit (Labor Diagnostica Nord, Nord-
horn, Germany) following the manufacturer’s instructions.
TAG and nonesterified fatty acids (NEFAs) were determined
by a triglyceride kit (Sigma-Aldrich, Madrid, Spain) and NEFA-
HR detection kit (Wako Diagnostics, Richmond, VA),
respectively.
Pyruvate dehydrogenase activity assay
Pyruvate dehydrogenase (PDH) activity was measured
using a Microplate Assay Kit (Abcam, Cambridge, UK). PDH
was immunocaptured in the microplate and activity was de-
termined by following the reduction of NAD+ to NADH cou-
pled to a reduction in a reporter dye, the concentration of which
could be monitored by absorbance at 450 nm. Muscle tissue
(50 mg) was homogenized in phosphate-buffered saline in the
presence of protease, phosphatase, and kinase inhibitors.
Samples were then solubilized and diluted according to the
manufacturer’s instructions, the reaction mixture was added,
and absorbance was recorded at 30°C every minute for
15 minutes.
RNA extraction and real-time polymerase
chain reaction
Total RNA was extracted using Trizol reagent (Fisher Scientific,
Madrid, Spain) according to the manufacturer’s recommendations.
For gene expression analysis, template cDNA was obtained from 1
mg of total RNA by reverse transcription using Moloney2Murine
LeukemiaVirus (M-MLV) reverse transcription and randomprimers
(Fisher Scientific,Madrid, Spain).Of the reaction, 1/20wasusedwith
the polymerase chain reaction (PCR) mix SsoAdvanced SYBRGreen
Supermix (BioRad, Madrid, Spain) for quantitative real-time PCR
(CFX96 Real-time System; BioRad, Madrid, Spain). The following
gene-specific intron-skipping primers (IDT DNA Technologies,
Leuven, Belgium) were used: CPT1C (for-TATGCAGTCGC-
CCTTCCT, rev-ACATCAATCAGGTGTGTCTGCT); UCP2 (for-
GCTCAGCACAGTTGACAATG, rev-CCTACAAGACCATTG-
CACGA); pyruvate dehydrogenase 4 (PDK4 for-CGCTTAGT-
GAACACTCCTTCG, rev-CTTCTGGGCTCTTCTCATGG);
phosphoenolpyruvate carboxykinase (PEPCK; for-GATGACA-
TTGCCTGGATGAA, rev-AACCGTTTTCTGGGTTGATG);
CPT1B (for-TGCCTTTACATCGTCTCCAA, rev-GGCTCC-
AGGGTTCAGAAAGT), and glyceraldehyde 3-phosphate
dehydrogenase (for-TCCACTTTGCCACTGCA, rev-
GAGACGGCCGCATCTTCTT). Relative gene expression was
estimated using the comparative Ct (2-DDct) method in relation
to glyceraldehyde 3-phosphate dehydrogenase levels.
Western blot analysis
Tissue was homogenized in radioimmunoprecipitation assay
buffer (Sigma-Aldrich) containing protease and phosphatase
inhibitor cocktails. Liver and muscle were homogenized using
the Fast-Prep-24 homogenizer (MP Biomedicals, Santa Ana,
CA) and the MBH was sonicated. Next, protein extracts were
separated on sodium dodecyl sulfate polyacrylamide gels
(Criterion Precast Gel; BioRad) and then transferred into
Immobilion-P PVDF membranes (Merck Millipore, Madrid,
Spain). Blots were blocked with 5% (w/v) dry milk in Tris-
buffered saline with Tween 20 and incubated overnight at 4°C
with the following primary antibodies in Tween 20 with 0.2%
(w/v) bovine serum albumin: Sirtuin 1 [Sirt1; catalog no. 07-
131, Research Resource Identifier (RRID): AB_11214517;
MerckMillipore], pAMPK (catalog no. 2535, RRID: AB_331250;
Cell Signaling, Danvers, MA), mammalian target of rapamycin
(mTOR) and phospho-mTOR (catalog no. 2972 and 2971, RRID:
AB_330978 andAB_330970, respectively; Cell Signaling), CPT1A
(32), CPT1C (16), and b-actin (catalog no. ma1-91399, RRID:
AB_2273656; Fisher Scientific). After washing, blots were in-
cubatedwith horseradish peroxidase (HRP)-conjugated secondary
antibodies [anti-mouse immunoglobulin M (IgM) HRP and anti-
rabbit IgG HRP, RRID: AB_258413 and AB_390191, re-
spectively)] and developed using LuminataForte Western HRP
substrate (Merck Millipore). Semiquantitative analysis was per-
formed using densitometry GeneTools software (Syngene, Cam-
bridge, UK), and b-actin was used as an endogenous control to
normalize protein expression levels.
Statistical analysis
Data are expressed as mean 6 standard error of the mean
(SEM). Statistical analysis of differences was performed using
GraphPad Prism Software (GraphPad Software, La Jolla, CA).
The two-way analysis of variance test was used to analyze the
effects of two different independent variables (the genotype and
the feeding status), followed by post hoc analysis. Experiments
in which data were repeatedly collected over timewere analyzed
by repeated measures of analysis of variance. For all analyses,
significant values were set at P , 0.05.
Results
CPT1C KO mice show impaired regulation of
hypothalamic energy and nutrient sensors in
response to fasting
We first analyzed the expression of CPT1C in the
MBH and in the whole hypothalamus. Notably, CPT1C
expression in the MBH was increased after 24 hours of
fasting in wild-type (WT) mice [Fig. 1(a)], suggesting a
role for CPT1C in this hypothalamic area when nutrient
availability is compromised. Then we analyzed the ex-
pression or phosphorylation grade of several relevant
energymetabolic markers in theMBHof CPT1CKO and
WT mice during the fed-to-fast transition. Fasting is
known to trigger activation of the energy sensor AMPK in
the hypothalamus (33, 34). As expected, phosphorylated
AMPK levels increased after 24 hours of fasting in WT
mice [Fig. 1(b)]. By contrast, CPT1C KO mice showed
increased pAMPK levels in the fed state, which were
decreased after fasting [Fig. 1(b)].
Because AMPK promotes FAO at the cellular level,
we analyzed the expression of UCP2, which is activated
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to regulate mitochondrial reactive oxygen species de-
rived from FAO. Consistent with the pAMPK levels,
the fasting-induced UCP2 rise was completely abol-
ished in CPT1C KO mice [Fig. 1(c)]. Moreover, in the
MBH of fasted CPT1C KO mice, mTOR, a sensor of
nutrient availability (35, 36), showed a higher rate of
phosphorylation [i.e. activation; Fig. 1(d)] than in WT
mice. The expression of Sirt1, a NAD+-dependent
deacetylase that is a key mediator of the central re-
sponse to low nutritional availability (37), showed a
tendency to be decreased in CPT1C KO mice during
fasting compared with the fed state [Fig. 1(e)], whereas
it did not change in WT mice. These results combined
suggest that CPT1C deficiency causes dysregulation of
nutrient- and energy-sensing markers in MBH in re-
sponse to fasting.
Figure 1. Hypothalamic energy sensors are disrupted in CPT1C KO mice in response to 24 hours of fasting. (a) CPT1C mRNA levels in
MBH and whole hypothalamus of WT mice. Protein levels of (b) pAMPK, (d) pmTOR, and (e) Sirt1 were measured by Western blot in
MBH of WT and CPT1C KO mice. (c) UCP2 mRNA expression levels were measured by real-time PCR. Results are represented as mean 6
SEM (n = 6 to 8). *P , 0.05, **P , 0.01 relative to fed state within the same genotype; #P , 0.05, ##P , 0.01 relative to WT under the
same diet conditions. A.U., arbitrary unit.
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Fasting-induced liver FAO is impaired in CPT1C
KO mice
At the peripheral level, AMPK is an important energy
sensor that contributes to activating FAO during glucose
scarcity. AMPK induces the expression of CPT1A, which
facilitates the entrance of LCFAs into mitochondria for
their b-oxidation, and PDK4, which phosphorylates and
inhibits PDH enzyme. Consequently, FAO is activated and
pyruvate oxidation is inhibited, allowing the utilization of
the pyruvate surplus as gluconeogenic substrate. We found
that liver pAMPK levels were increased in WT mice fasted
for 24 hours, whereas this rise was blunted in CPT1C KO
mice [Fig. 2(a) and2(b)].Moreover, livers fromCPT1CKO
mice showed decreased levels of CPT1A and PDK4 after
fasting when compared with WT mice [Fig. 2(c) and 2(d)],
indicating that FAO induction was impaired and glucose-
derived pyruvate oxidation was prevalent over FAO. In
keeping with this, CPT1C KOmice exhibited elevated TAG
levels after 24 hours of fasting [Fig. 2(e)], and almost com-
plete glycogen depletion after 6 hours of fasting [Fig. 2(f)].
These findings are suggestive that the switch in fuel substrate
use in the liver is not properly activated in CPT1C KOmice.
CPT1C KO mice show defective muscle FAO
activation during fasting
A similar pattern to liver-defective nutrient partitioning
was observed in the gastrocnemius muscle of CPT1C KO
mice. AMPK showed a tendency to be activated inWTmice
during fasting, but this effect was not observed in CPT1C
KO mice [Fig. 3(a)]. Moreover, a significant induction of
CPT1B expression was not observed [Fig. 3(b)]. More in-
terestingly, PDH activity in muscle homogenates from
fasted CPT1C KO mice was induced instead of inhibited
[Fig. 3(c)]. These results indicate that nutrient partitioning is
also impaired in the muscle of these mice, which continues
to use glucose-derived pyruvate as fuel, instead of switching
the energetic substrate to fatty acids. Remarkably, muscle
glycogen content declined at the same rate in WT and KO
mice during fasting [Fig. 3(d)], suggesting that the circu-
lating glucosewas the fuel used to feedmuscle PDHactivity.
CPT1C KO mice show increased hepatic
gluconeogenesis but normal fasting glycaemia
Because results reported thus far for this study in-
dicated that the liver and muscle of CPT1C KO mice
keep using glucose as fuel substrate during food dep-
rivation, we analyzed whether CPT1C KO mice had
more severe hypoglycemia thanWTmice after 48 hours
of fasting. Our results showed that both genotypes had
the same blood glucose levels after long fasting [Fig.
4(a)], demonstrating an accurate control of glycemia by
CPT1C KO mice. We then explored whether liver glu-
coneogenesis was increased to counteract muscular
glucose use. Liver PEPCK mRNA levels (a well-
established gluconeogenesis marker) were higher in fas-
ted CPT1C KO mice than in WT mice [Fig. 4(b)]. In
addition, we performed a pyruvate tolerance test to
overnight fasted animals and found that blood glucose
levels after pyruvate administration were higher in
CPT1C KO mice than in WT mice, confirming the major
Figure 2. Impaired liver nutrient partitioning in CPT1C KO mice. (a) A representative Western blot analysis of pAMPK and CPT1A expression in liver
homogenates from WT and CPT1C KO mice. Quantification of (b) pAMPK and (c) CPT1C protein expression levels. (d) Nutrient switch metabolism was
measured by mRNA levels of PDK4 quantified from total RNA extracts. (e) Hepatic TAG and (f) glycogen content of fed and fasted WT and CPT1C KO
mice. Results are represented as mean 6 SEM (n = 6 to 8). *P , 0.05, **P , 0.01, ***P , 0.005 relative to fed state within the same genotype;
#P , 0.05, ##P , 0.01, ###P , 0.005 relative to WT under the same diet conditions. A.U., arbitrary unit.
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increase in hepatic gluconeogenesis in CPT1C-deficient
mice during fasting [Fig. 4(c)]. Overall, these data indicate
that although the liver of CPT1C KO fails to switch fuel
use from glucose to fatty acids, it is able to adapt the
gluconeogenesis rate for a precise control of blood
glucose levels.
Fasting-induced decrease in adiposity is attenuated
in CPT1C KO mice
Because CPT1C KO mice present a defect in liver and
muscle use of lipids, we next analyzed whether lipid
mobilization from fat stores was affected. The fasting-
induced reduction of eWAT was lower in CPT1C KO
mice than in WT mice [WT: 60% vs KO: 34%;Fig. 5(a)],
which is consistent with lower use of fatty acids as fuel by
peripheral tissues. Accordingly, CPT1C KO mice dis-
played resistance to losingweight after 48 hours of fasting
[Fig. 5(b)]. Interestingly, CPT1C KO mice exhibited
decreased plasma norepinephrine levels after fasting
compared with control mice [Fig. 5(c)], which could
partially explain the reduced mobilization of fats. We
also measured plasma NEFA and TAG and found no
differences between the genotypes [Fig. 5(d)]. In both
genotypes, NEFA levels were increased and TAG levels
were reduced at fasting, as expected for the WT mice.
This suggests that the reduced delivery of NEFA from
eWAT in CPT1C KO mice at fasting is counteracted by
the lower FAO in liver and muscle.
The inability of CPT1C KO mice to properly use fatty
acids as fuel appeared to have long-term consequences.
CPT1CKOmice showed higher adiposity and lower lean
mass than WT mice [Fig. 5(e)]. In addition to reshaped
body composition, CPT1C KO mice presented higher
body weight gain with age [Fig. 5(f)], which was in-
dependent of food intake [Fig. 5(g)].
Finally, to confirm that CPT1C-deficient mice do not
properly switch fuel substrate at fasting, we performed in-
direct calorimetryunder ad libitum fed and fasted conditions.
Results showed that the RQ (CO2 production divided by
oxygen consumption) of WT mice decreased at fasting,
whereas it remained unaffected in CPT1C KO mice
[Fig. 5(h)], confirming the incapacity of those mice to pro-
mote liver and muscle FAO under food deprivation. No-
tably, no differences were observed in energy expenditure
Figure 3. Impaired muscle nutrient partitioning in CPT1C KO mice. (a) Gastrocnemius muscle was isolated from WT and CPT1C KO mice to
measure pAMPK protein levels, (b) CPT1B mRNA levels, (c) PDH activity, and (d) glycogen content. Results are represented as mean 6 SEM (n = 6
to 8). *P , 0.05 relative to fed state within the same genotype; ##P , 0.01 relative to WT under the same diet conditions. A.U., arbitrary unit.
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(Supplemental Fig. 1) and locomotor activity (Supplemental
Fig. 2) either in light or dark phase in CPT1C KO mice
compared with control animals.
CPT1C overexpression specifically in the MBH is
sufficient to reverse the metabolic phenotype of
CPT1C KO mice
To further confirm the involvement of CPT1C in pe-
ripheral metabolic regulation, we specifically expressed
CPT1C in the MBH of CPT1C KO mice through bilateral
and intraparenchyma stereotaxic injection of lentivirus
harboring CPT1C [the experimental timing diagram is
shown in Fig. 6(a)]. Overexpression of CPT1C in theMBH
was assessed by the presence of fluorescence in the his-
tological sections [Fig. 6(b)]. Western blot analysis of
MBH punches revealed that CPT1C KO mice injected
with CPT1C-GFP harboring viruses expressed 66.9% 6
1.4% levels of CPT1C with respect to WT mice injected
with GFP viruses [Fig. 6(c)]. Overexpression of CPT1C
ameliorated the defects in nutrient partitioning in liver
and muscle, as evidenced by the restored response in
liver PDK4 levels [Fig. 6(d)] and the trend in muscle
Figure 4. (a) Glucose homeostasis in WT and CPT1C KO mice. Glycemia after 48 hours of fasting is indicated. (b) PEPCK mRNA levels were determined
by quantitative PCR analysis. (c) A pyruvate tolerance test was performed in WT and CPT1C KO mice after an overnight fast; plasma glucose levels and
AUC are represented. Results are represented as mean 6 standard error of the mean (SEM; n = 6 to 8). *P , 0.05, **P , 0.01, ***P , 0.005 relative
to fed state within the same genotype; ##P , 0.01 relative to WT under the same diet conditions. A.U., arbitrary unit; AUC, area under the curve.
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Figure 5. Adiposity, plasma catecholamine levels, and RQ in WT and CPT1C KO mice. (a) eWAT tissue was weighed in fed and 24-hour fasted
animals. (b) Body weight was measured after 24 and 48 hours of fasting. (c) Plasma catecholamine levels in fed and 24-hour fasted animals. (d)
NEFA and TAG levels in fed and 24-hour fasted mice. (e) Body mass composition was measured by nuclear magnetic resonance imaging. (f) Body
weight gain and (g) 24-hour food intake were monitored monthly until animals reached 12 months of age. Refeeding was calculated as 24-hour
food intake after 24 hours of fasting, at 10 months of age. RQ was measured by indirect calorimetry. (h) Mice were maintained 48 hours at
normal conditions and 48 hours under fasting. Results are represented as mean 6 SEM (n = 6 to 8). *P , 0.05, **P , 0.01, ***P , 0.005
relative to fed state within the same genotype; #P , 0.05 relative to WT under the same diet conditions. Epi, epinephrine; Norepi,
norepinephrine.
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Figure 6. MBH-specific overexpression of CPT1C reverses the fasting phenotype of CPT1C KO mice. (a) GFP or CPT1C-GFP expressing lentiviruses
were microinjected bilaterally in the MBH of WT and CPT1C KO mice, and 1 week later were exposed to 24-hour fasting. Half of the mice group
was used to confirm the proper injection site by histological analysis, and the other half to analyze CPT1C expression in MBH by Western blot.
(b) A representative image of GFP fluorescence photomicrograph of virus expression localization in the MBH region is shown. (c) Western blot
analysis. (d) Liver PDK4 mRNA levels, (e) muscle PDH activity, and (f) liver PEPCK mRNA levels are shown. (g) Body weight loss is indicated. Results
are represented as mean 6 SEM (n = 5 to 6). *P , 0.05, **P , 0.01. A.U., arbitrary unit.
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PDH activity to be reduced [Fig. 6(e)]. In accordance
with a re-established fuel tunneling, liver PEPCKmRNA
levels were decreased, indicative of a restored liver glu-
coneogenesis [Fig. 6(f)]. Moreover, all these responses
where associated to normalization of the fasting-induced
body weight loss [Fig. 6(g)].
Discussion
In this study, we demonstrate the mechanisms by which
hypothalamic CPT1C regulates hepatic andmuscular key
enzymes involved in nutrient partitioning during negative
energy balance, such as fasting. Fuel use of fat stores over
carbohydrates in peripheral tissues is a crucial metabolic
adaptation to preserve plasma glucose for brain meta-
bolism, avoiding fainting and, hence, maintaining
appropriated cognitive functions during fasting.
First, we demonstrated that CPT1C expression is trig-
gered by fasting in the MBH, a hypothalamic area con-
taining glucose and fatty-acid–sensing neurons (38, 39) and
closely related to peripheral metabolism regulation (40,
41), suggesting a key role of CPT1C in nutrient-scarce
conditions. Here, we showed that CPT1C deficiency
completely blunts the canonical AMPK-UCP2 pathway in
MBH, which ought to be activated during fasting (42, 43).
Hypothalamic AMPK drives the shift from negative to
neutral energy balance (14), and UCP2 in agouti-related
protein/Neuropeptide Y neurons promotes FAO over
glucose use during food deprivation (44, 45), so its im-
pairment inCPT1CKOmice can account for themetabolic
inflexibility of these mice. Moreover, the energy markers
Sirt1 and mTOR did not respond properly to changes in
nutrient availability in the MBH of CPT1C-deficient mice,
confirming the involvement of CPT1C in hypothalamic
sensing of nutrient deprivation. On the other hand, recent
observations suggest that synaptic plasticity is a component
in the hypothalamic control of energy homeostasis
(46–49). CPT1C has been demonstrated to regulate the
trafficking of AMPA-type glutamate receptors and den-
dritic spinogenesis (24, 50–53); therefore, further work
will be worthwhile to address the putative role of CPT1C
in hypothalamic synaptic plasticity.
At the peripheral level, fasting does not properly ac-
tivate the autonomous nervous system in CPT1C KO
mice, resulting in decreased plasma catecholamine levels,
which may be the cause, at least partially, of impaired
responses of liver and muscle to fasting. In liver, CPT1C
KOmice show a clear deregulation of the AMPK-CPT1A
axis (FAO enhancers), and the AMPK downstream factor
PDK4, which is a key kinase responsible for switching
nutrient use from carbohydrates to fatty acids (54, 55).
This inability to switch fuel substrates during fasting
causes major TAG synthesis and accumulation in the
liver, as well as a higher depletion of hepatic glycogen
stores in CPT1C KO mice.
The major alteration observed in these mice at the
muscular level is a marked activation of PDH activity
during fasting, instead of the inhibition observed in WT
mice. PDH activity together with PDK4 expression are
crucial in nutrient partitioning in muscle (56). The in-
appropriate suppression of PDH activity and the major
pyruvate-derived tricarboxylic flux should produce a
major decrease in muscle glycogen stores in CPT1C-
deficient mice; however, that was not the case, suggest-
ing that those mice were using blood glucose as the main
substrate. Meanwhile, fasting blood glucose in CPT1C
KO mice remained exactly the same as in WT mice,
probably due to the increased hepatic gluconeogenesis
observed. However, we cannot rule out the potential role
of proteolysis and amino acid metabolism as an alter-
native energy source in this context, which could partially
contribute to the maintenance of normal glucose levels in
CPT1C KO mice.
Results indicate that although CPT1C-deficient mice
are unable to properly regulate the peripheral switch in
fuel substrate during fasting, they are better able to exert
an effective counter-response in glucose production to
maintain intact plasma glycemia than are WT mice, in-
dicating that CPT1C is not directly involved in the reg-
ulation of glucose homeostasis. Interestingly, the other
brain isoform, CPT1A, is involved in theMBH regulation
of liver glucose production in response to nutrient signals
(4, 5). It seems that the two different CPT1 isoforms in the
MBH are regulating different aspects of liver metabolism:
counter-response glucose production (by CPT1A) and
fuel selection (by CPT1C).
The physiological relevance of these observations is
supported by the data from indirect calorimetry, which
shows the inability of CPT1C-deficient mice to reduce
the RQ (which is indicative of lipid use) after fasting,
meaning that these mice continue to use carbohydrates as
fuel substrate. As a result of this impairment, CPT1C KO
mice exhibit a feeding-independent weight gain and ad-
iposity. Remarkably, low carbohydrate reserves in sub-
jects with low-fat oxidation have been associated with
increased weight gain in humans (57), resembling the
phenotype of CPT1C deficiency in mice.
Finally, the mechanistic relevance of our data were
given by the fact that lentiviral-driven overexpression of
CPT1C, specifically in theMBH of CPT1CKOmice, was
enough to (1) restore PDK4 and PEPCK expression levels
in the liver, (2) reduce muscular PDH activity, and (3)
promote effective body weight loss during fasting. Al-
though the experimental model used here was a global
CPT1C-deficient mouse, these results are indicative of a
key role of CPT1C in MBH.
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In summary, this study improves the mechanistic
understanding of the CPT1C role in fuel selection of
peripheral tissues at fasting and identifies theMBH as the
major brain area where CPT1C exerts its effects. These
findings highlight the function of CPT1C as a central
coordinator of peripheral energy partitioning and con-
firm CPT1C as a putative target in the treatment of
obesity and other related pathologies.
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L’Oréal-UNESCO “For Women in Science” research fellowships
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6. Contreras C, González-Garcı́a I, Martı́nez-Sánchez N, Seoane-
Collazo P, Jacas J, Morgan DA, Serra D, Gallego R, Gonzalez F,
Casals N, Nogueiras R, Rahmouni K, Diéguez C, LópezM. Central
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12. López M, Varela L, Vazquez MJ, Rodriguez-Cuenca S, Gonzalez
CR, Velagapudi VR, Morgan DA, Schoenmakers E, Agassandian
K, Lage R, de Morentin PBM, Tovar S, Nogueiras R, Carling D,
Lelliott C, Gallego R, Oresic M, Chatterjee K, Saha AK, Rahmouni
K, Dieguez C, Vidal-Puig A. Hypothalamic AMPK and fatty acid
metabolism mediate thyroid regulation of energy balance. Nat
Med. 2010;16(9):1001–1008.
13. López M, Nogueiras R, Tena-Sempere M, Diéguez C. Hypotha-
lamic AMPK: a canonical regulator of whole-body energy balance.
Nat Rev Endocrinol. 2016;12(7):421–432.
14. Stark R, Ashley SE, Andrews ZB. AMPK and the neuroendocrine
regulation of appetite and energy expenditure. Mol Cell Endo-
crinol. 2013;366(2):215–223.
15. Zaugg K, Yao Y, Reilly PT, Kannan K, Kiarash R,Mason J, Huang
P, Sawyer SK, Fuerth B, Faubert B, Kalliomäki T, Elia A, Luo X,
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